Workers describe a deteriorating culture at Block, the company behind Square and Cash App, where layoffs continue and employees are expected to use AI tools daily. “Morale is probably the worst I’ve ...

The fat that can be seen and pinched is subcutaneous. It is located right under the skin and is usually located around the hips, thighs, arms, and abdomen. Though surplus fat in the body may cause ...

A Prescription Drug User Fee Act target date of May 24, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License ...

Subcutaneous (SC) formulations of monoclonal antibodies are rapidly transforming the delivery of cancer immunotherapy. Designed to replace or complement intravenous (IV) administration, SC delivery ...

The shares of Block, Inc. (NYSE: XYZ), the financial technology company led by Twitter co-founder Jack Dorsey, halted trading on Nov. 19 when the Bitcoin (BTC)-focused company made a major ...

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Subcutaneous amivantamab-lazertinib demonstrated noninferior ...

Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.

Block's sales and earnings missed Wall Street's targets in the third quarter. Revenue performance came in far weaker than expected. Block raised its full-year gross profit target, but higher costs in ...

Keytruda Qlex is now FDA-approved for subcutaneous use in patients 12 and older with solid tumors, offering an alternative to IV administration. Subcutaneous administration can improve patient ...

Offshore turbines let Block Island shut down soot-spewing, earsplitting diesel generators. There were other benefits, too. 50 States, 50 Fixes Offshore turbines let Block Island shut down soot-spewing ...

Please provide your email address to receive an email when new articles are posted on . Patients who received subcutaneous amivantamab-vmjw every 4 weeks plus lazertinib had similar outcomes as those ...

The FDA has approved a subcutaneous formulation of lecanemab (Leqembi Iqlik, Eisai/Biogen) for maintenance dosing in patients with Alzheimer’s disease (AD) with mild cognitive impairment (MCI) or mild ...